These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7809953)

  • 81. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes.
    Regier PS; Kampman KM; Childress AR
    Handb Exp Pharmacol; 2020; 258():299-322. PubMed ID: 32193666
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands.
    Bergman J; France CP; Holtzman SG; Katz JL; Koek W; Stephens DN
    Psychopharmacology (Berl); 2000 Dec; 153(1):67-84. PubMed ID: 11255930
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Confronting the challenge of failed translation in medications development for substance use disorders.
    Negus SS; Banks ML
    Pharmacol Biochem Behav; 2021 Nov; 210():173264. PubMed ID: 34461148
    [No Abstract]   [Full Text] [Related]  

  • 84. A mechanistic overview of approaches for the treatment of psychostimulant dependence.
    Jensen KL; Jensen SB; Madsen KL
    Front Pharmacol; 2022; 13():854176. PubMed ID: 36160447
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Psychostimulant use disorder and the heart.
    Duflou J
    Addiction; 2020 Jan; 115(1):175-183. PubMed ID: 31321853
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Role of Microglia in Psychostimulant Addiction.
    da Silva MCM; Iglesias LP; Candelario-Jalil E; Khoshbouei H; Moreira FA; de Oliveira ACP
    Curr Neuropharmacol; 2023; 21(2):235-259. PubMed ID: 36503452
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies.
    Karimi-Haghighi S; Mahmoudi M; Sayehmiri F; Mozafari R; Haghparast A
    Eur J Pharmacol; 2023 Jul; 951():175669. PubMed ID: 36965745
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans.
    Taylor SB; Lewis CR; Olive MF
    Subst Abuse Rehabil; 2013; 4():29-43. PubMed ID: 24648786
    [TBL] [Abstract][Full Text] [Related]  

  • 89. 'Crack'. Early report on a new drug epidemic.
    Washton AM; Gold MS; Pottash AC
    Postgrad Med; 1986 Oct; 80(5):52-4, 57-8. PubMed ID: 3763534
    [No Abstract]   [Full Text] [Related]  

  • 90. Exercise intervention can reduce the degree of drug dependence of patients with amphetamines/addiction by improving dopamine level and immunity and reducing negative emotions.
    He Q; Wu J; Wang X; Luo F; Yan K; Yu W; Mo Z; Jiang X
    Am J Transl Res; 2021; 13(3):1779-1788. PubMed ID: 33841702
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Biologic Approaches to Treat Substance-Use Disorders.
    Skolnick P
    Trends Pharmacol Sci; 2015 Oct; 36(10):628-635. PubMed ID: 26435208
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Authors' Response.
    Curley LJ; Munro J; Lages M; MacLean R; Murray J
    J Forensic Sci; 2020 Mar; 65(2):668-670. PubMed ID: 31995236
    [No Abstract]   [Full Text] [Related]  

  • 93. Authors' Response.
    Wang X; Xiang P; Shen M
    J Forensic Sci; 2020 Mar; 65(2):665. PubMed ID: 31651993
    [No Abstract]   [Full Text] [Related]  

  • 94. Functional analysis of the D2L dopamine receptor expressed in a cAMP-responsive luciferase reporter cell line.
    George SE; Bungay PJ; Naylor LH
    Biochem Pharmacol; 1998 Jul; 56(1):25-30. PubMed ID: 9698085
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of isoflurane anesthesia on addictive behaviors in rats.
    Yoon SS; Lee BH; Lee SH; Choi SH; Jeong SJ; Kim SC; Yang CH
    Psychopharmacology (Berl); 2022 Nov; 239(11):3621-3632. PubMed ID: 36109391
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Noni (Morinda citrifolia L.) fruit extract attenuates the rewarding effect of heroin in conditioned place preference but not withdrawal in rodents.
    Narasingam M; Pandy V; Mohamed Z
    Exp Anim; 2016 May; 65(2):157-64. PubMed ID: 26744024
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism.
    de Bartolomeis A; Tomasetti C; Iasevoli F
    CNS Drugs; 2015 Sep; 29(9):773-99. PubMed ID: 26346901
    [TBL] [Abstract][Full Text] [Related]  

  • 98. New view on treatment of drug dependence.
    Ranjbaran M; Sahraei H
    Basic Clin Neurosci; 2014; 5(1):96-7. PubMed ID: 25436090
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm.
    John WS; Banala AK; Newman AH; Nader MA
    Psychopharmacology (Berl); 2015 Apr; 232(7):1279-89. PubMed ID: 25327444
    [TBL] [Abstract][Full Text] [Related]  

  • 100. l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.
    Wang JB; Mantsch JR
    Future Med Chem; 2012 Feb; 4(2):177-86. PubMed ID: 22300097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.